Long-term results and predictors of survival after surgical resection of patients with lung cancer and interstitial lung diseases

Journal of Thoracic and Cardiovascular Surgery

Volumn 149, Issue 1, 2015, Pages 64-70.e2

  Sato, Toshihiko ^a   Watanabe, Atsushi ^b   Kondo, Haruhiko ^c   Kanzaki, Masato ^d   Okubo, Kenichi ^e   Yokoi, Kohei ^f   Matsumoto, Kazuya ^g   Marutsuka, Takashi ^h   Shinohara, Hirohiko ⁱ   Teramukai, Satoshi ^j   Kishi, Kazuma ^k   Ebina, Masahito ^l   Sugiyama, Yukihiko ^m   Meinoshin, Okumora ⁿ   Date, Hiroshi ^a  

^a KYOTO UNIVERSITY   (Japan)

^b SAPPORO MEDICAL UNIVERSITY   (Japan)

^c KYORIN UNIVERSITY   (Japan)

^d TOKYO WOMEN S MEDICAL UNIVERSITY MEDICAL CENTER EAST   (Japan)

^e TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

^f NAGOYA UNIVERSITY HOSPITAL   (Japan)

^g Kishiwada City Hospital   (Japan)

^h KUMAMOTO CHUO HOSPITAL   (Japan)

ⁱ NIIGATA UNIVERSITY GRADUATE SCHOOL OF MEDICAL AND DENTAL SCIENCES   (Japan)

^j KANAZAWA UNIVERSITY   (Japan)

^k TORANOMON HOSPITAL   (Japan)

^l Tohoku Medical and Pharmaceutical University Hospital   (Japan)

^m JICHI MEDICAL UNIVERSITY   (Japan)

ⁿ Oosaka Medical Center for Cancer and Cardiovascular Diseases   (Japan)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CANCER LOCALIZATION; CANCER MORTALITY; CANCER PROGNOSIS; CANCER RECURRENCE; CANCER RISK; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; CAUSE OF DEATH; CLINICAL EVALUATION; CONTROLLED STUDY; DISEASE EXACERBATION; FEMALE; HUMAN; INTERSTITIAL LUNG DISEASE; INTERSTITIAL PNEUMONIA; LONG TERM SURVIVAL; LUNG FIBROSIS; LUNG LOBECTOMY; LUNG RESECTION; MAJOR CLINICAL STUDY; MALE; MORBIDITY; NON SMALL CELL LUNG CANCER; OVERALL SURVIVAL; PATIENT RISK; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; RESPIRATORY FAILURE; RETROSPECTIVE STUDY; RISK ASSESSMENT; RISK FACTOR; SEGMENTECTOMY; SMOKING; SURGICAL TECHNIQUE; SURVIVAL RATE; VITAL CAPACITY; WEDGE RESECTION; CARCINOMA, NON-SMALL-CELL LUNG; CLINICAL TRIAL; COMPARATIVE STUDY; JAPAN; KAPLAN MEIER METHOD; LUNG; LUNG DISEASES, INTERSTITIAL; LUNG NEOPLASMS; MIDDLE AGED; MORTALITY; MULTICENTER STUDY; MULTIVARIATE ANALYSIS; PATHOLOGY; PATHOPHYSIOLOGY; PATIENT SELECTION; PROPORTIONAL HAZARDS MODEL; RESPIRATORY INSUFFICIENCY; RISK; STATISTICAL MODEL; TIME; TREATMENT OUTCOME; TUMOR RECURRENCE; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, NON-SMALL-CELL LUNG; CAUSE OF DEATH; FEMALE; HUMANS; JAPAN; KAPLAN-MEIER ESTIMATE; LOGISTIC MODELS; LUNG; LUNG DISEASES, INTERSTITIAL; LUNG NEOPLASMS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; ODDS RATIO; PATIENT SELECTION; PNEUMONECTOMY; PROPORTIONAL HAZARDS MODELS; RESPIRATORY INSUFFICIENCY; RETROSPECTIVE STUDIES; RISK ASSESSMENT; RISK FACTORS; TIME FACTORS; TREATMENT OUTCOME; VITAL CAPACITY;

EID: 84922309383     PISSN: 00225223     EISSN: 1097685X     Source Type: Journal    
DOI: 10.1016/j.jtcvs.2014.08.086     Document Type: Article

References (23)

1. Kumar P, Goldstraw P, Yamada K, Nicholson AG, Wells AU, Hansell DM, et al. Pulmonary fibrosis and lung cancer: risk and benefit analysis of pulmonary resection. J Thorac Cardiovasc Surg. 2003;125:1321-7.
2. Raghu G, Nyberg F, Morgan G. The epidemiology of interstitial lung disease and its association with lung cancer. Br J Cancer. 2004;91(Suppl 2):S3-10.
3. Ozawa Y, Suda T, Naito T, Enomoto N, Hashimoto D, Fujisawa T, et al. Cumulative incidence of and predictive factors for lung cancer in IPF. Respirology. 2009;14:723-8.
4. Sato T, Teramukai S, Kondo H, Watanabe A, Ebina M, Kishi K, et al. Impact and predictors of acute exacerbation of interstitial lung diseases after pulmonary resection for lung cancer. J Thorac Cardiovasc Surg. 2014;147:1604-11.e3.
5. Sobin LH, Wittekind C, eds. International Union Against Cancer (UICC), TNM Classification of Malignant Tumors. 6th ed. New York:Wiley-Liss; 2002:99-103.
6. Raghu G, Collard HR, Egan JJ, Martinez FJ, Behr J, Brown KK, et al. An official ATS/ERS/JRS/ALAT statement: idiopathic pulmonary fibrosis: evidence-based guidelines for diagnosis and management. Am J Respir Crit Care Med. 2011; 183:788-824.
7. Schwartz DA, Helmers RA, Galvin JR, Van Fossen DS, Frees KL, Dayton CS, et al. Determinants of survival in idiopathic pulmonary fibrosis. Am J Respir Crit Care Med. 1994;149:450-4.
8. Mapel DW, Hunt WC, Utton R, Baumgartner KB, Samet JM, Coultas DB. Idiopathic pulmonary fibrosis: survival in population based and hospital based cohorts. Thorax. 1998;53:469-76.
9. Saito Y, Kawai Y, Takahashi N, Ikeya T, Murai K, Kawabata Y, et al. Survival after surgery for pathologic stage IA non-small cell lung cancer associated with idiopathic pulmonary fibrosis. Ann Thorac Surg. 2011;92:1812-7.
10. Watanabe A, Higami T, Ohori S, Koyanagi T, Nakashima S, Mawatari T. Is lung cancer resection indicated in patients with idiopathic pulmonary fibrosis? J Thorac Cardiovasc Surg. 2008;136:1357-63. 63 e1-2.
11. Watanabe A, Kawaharada N, Higami T. Postoperative acute exacerbation of IPF after lung resection for primary lung cancer. Pulm Med. 2011;2011:960316.
12. Fujimoto T, Okazaki T, Matsukura T, Hanawa T, Yamashita N, Nishimura K, et al. Operation for lung cancer in patients with idiopathic pulmonary fibrosis: surgical contraindication? Ann Thorac Surg. 2003;76:1674-8.
13. Chiyo M, Sekine Y, Iwata T, Tatsumi K, Yasufuku K, Iyoda A, et al. Impact of interstitial lung disease on surgical morbidity and mortality for lung cancer: analyses of short-term and long-term outcomes. J Thorac Cardiovasc Surg. 2003;126:1141-6.
14. Kawasaki H, Nagai K, Yoshida J, Nishimura M, Nishiwaki Y. Postoperative morbidity, mortality, and survival in lung cancer associated with idiopathic pulmonary fibrosis. J Surg Oncol. 2002;81:33-7.
15. Martinod E, Azorin JF, Sadoun D, Destable MD, Le Toumelin P, Longchampt E, et al. Surgical resection of lung cancer in patients with underlying interstitial lung disease. Ann Thorac Surg. 2002;74:1004-7.
16. Okamoto T, Gotoh M, Masuya D, Nakashima T, Liu D, Kameyama K, et al. Clinical analysis of interstitial pneumonia after surgery for lung cancer. Jpn J Thorac Cardiovasc Surg. 2004;52:323-9.
17. Sawabata N, Miyaoka E, Asamura H, Nakanishi Y, Eguchi K, Mori M, et al. Japanese lung cancer registry study of 11,663 surgical cases in 2004: demographic and prognosis changes over decade. J Thorac Oncol. 2011;6:1229-35.
18. Nishiyama O, Taniguchi H, Kondoh Y, Kimura T, Kato K, Kataoka K, et al. A simple assessment of dyspnoea as a prognostic indicator in idiopathic pulmonary fibrosis. Eur Respir J. 2010;36:1067-72.
19. Celli BR, Mac Nee W, ATS/ERS Task Force. Standards for the diagnosis and treatment of patients with COPD: a summary of the ATS/ERS position paper. Eur Respir J. 2004;23:932-46.
20. Hamada K, Nagai S, Tanaka S, Handa T, Shigematsu M, Nagao T, et al. Significance of pulmonary arterial pressure and diffusion capacity of the lung as prognosticator in patients with idiopathic pulmonary fibrosis. Chest. 2007;131:650-6.
21. Kutlu CA, Williams EA, Evans TW, Pastorino U, Goldstraw P. Acute lung injury and acute respiratory distress syndrome after pulmonary resection. Ann Thorac Surg. 2000;69:376-80.
22. Myrdal G, Gustafsson G, Lambe M, Horte LG, Stahle E. Outcome after lung cancer surgery. Factors predicting early mortality and major morbidity. Eur J Cardiothorac Surg. 2001;20:694-9.
23. Nishiyama O, Taniguchi H, Kondoh Y, Kimura T, Kato K, Ogawa T, et al. Dyspnoea at 6-min walk test in idiopathic pulmonary fibrosis: comparison with COPD. Respir Med. 2007;101:833-8.